In bronchial biopsies obtained from asthma and COPD patients, NF-κB is activated upon exposure to various environmental triggers, leading to pro-inflammatory responses (51) and therefore the activation of NF-κB may be a critical component of the pathogenesis of both diseases. This evidence concerns the gene NFKB1 and asthma.